Preparation, characterization, and evaluation of a monoclonal antibody against the rabbit platelet glycoprotein IIb/IIIa in an experimental angioplasty model

Circulation Research

Volumn 75, Issue 2, 1994, Pages 268-277

  Azrin, Michael A ^a,b   Ling, Frederick S ^a   Chen, Qinseng ^a   Pawashe, Aruna ^a   Migliaccio, Francesca ^a   Homer, Robert ^a   Todd, Mary ^a   Ezekowitz, Michael D ^a  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

angioplasty; antibody; glycoprotein IIb IIIa; platelet; restenosis

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; KETAMINE; LIDOCAINE; MONOCLONAL ANTIBODY AZ 1; UNCLASSIFIED DRUG; XYLAZINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL DIAMETER; BLOOD VESSEL INJURY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SYNTHESIS; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RABBIT; THROMBOCYTE AGGREGATION; TUNICA MEDIA;

EID: 0028341438     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.75.2.268     Document Type: Article

References (57)

1. Waller BF, Orr CM, Pinkerton CA, Van Tassel J, Peters T, Slack JD. Coronary balloon angioplasty dissections: "the good, the bad and the ugly." J Am Coll Cardiol. 1992;20:701-706.
2. Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka N, Hamasaki H, Yokoi H, Kim K. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol. 1991;17:433-439.
3. Friedman RJ, Stemerman MB, Wenz B, Moore S, Gauldie J, Gent M, Tiell ML, Spaet TH. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits: smooth muscle cell proliferation and re-endotheliazation. J Clin Invest. 1977;60: 1191-1201.
4. Moore S, Friedman RJ, Singal DP, Gauldie J, Blajchman M, Roberts RS. Inhibition of injury induced thromboatherosclerotic lesions by antiplatelet serum in rabbits. Thromb Haemost. 1976;35: 70-81.
5. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Cheseboro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 1990;15:1667-1687.
6. Liu MW, Roubin GS, King SB. Restenosis after coronary angioplasty: potential biologic determinants and role of intimai hyperplasia. Circulation. 1989;79:1374-1387.
7. Border WA, Ruoslahti E. Transforming growth factor β in disease: the dark side of tissue repair. J Clin Invest. 1992;90:1-7.
8. 1 during repair of arterial injury. J Clin Invest. 1991;88:904-910.
9. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
10. Faxon DP, Sanborn TA, Haudenschild CC, Ryan TS. The effect of antiplatelet therapy on restenosis following experimental angioplasty. Am J Cardiol. 1984;53(suppl):72C-76C.
11. Pick R, Chediak J, Click G. Aspirin inhibits development of coronary atherosclerosis in Cynomolgus monkeys fed an atherogenic diet. J Clin Invest. 1979;63:158-162.
12. Harker LA, Harlan JM, Ross R. Effect of sulfinpyrazone on homocystein-induced endothelial injury and arteriosclerosis. Circ Res. 1983;53:731-739.
13. Thornton MA, Gruentzig AR, Hollman J, King SB III, Douglas JS. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation. 1984;69:721-727.
14. Ellis SG, Roubin GS, Wilentz J, Liu S, Douglas JS, King SB III. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J. 1989;117:777-782.
15. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazim F, Salvatori VA, Henderson M, Bonan R, David PR. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med. 1988;318: 1493-1498.
16. Coller BS. Platelets and thrombolytic therapy. N Engl J Med. 1990; 322:33-42.
17. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein GPIIb-IIIa complex. Blood. 1988;71: 831-843.
18. Ardlie NG, Packham MA, Mustard JF. ADP induced platelet aggregation in suspensions of washed rabbit platelets. Br J Haematol. 1970;19:7-18.
19. +. J Lab Clin Med. 1975;85:811-825.
20. Kohler G, Milstein C. Continuous cultures of fused cells secreting an antibody of predetermined specificity. Nature. 1975;256: 495-497.
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
22. Bradford MB. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
23. Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol (Lond). 1963;168:178-195.
24. Pawashe, AB, Ezekowitz MD, Lin TC, Horton R, Bach R, Konigsberg WK. Molecular cloning, characterization and expression of cDNA for rabbit brain tissue factor. Thromb Haemost. 1991;66:315-320.
25. Pawashe AB, Golino P, Ambrosio G, Migliaccio F, Ragni M, Pascucci I, Chiariello M, Bach R, Garen A, Konigsberg WK, Ezekowitz MD. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res. 1994;74:56-63.
26. King SM, Otter T, Witman JB. A sensitive method for staining proteins transferred to nitrocellulose sheets. Proc Natl Acad Sci USA. 1985;82:4717-4721.
27. Wojkowiak Z, Briggs RC, Hnilica LS. Characterization of monoclonal antibody against chlamydomomas flagellar dyneinan by high-resolution protein blotting. Anal Biochem. 1983;129:486-489.
28. Burnette WN. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981;112: 195-203.
29. Gellman J, Ezekowitz MD, Sarembock IJ, Azrin MA, Nochomovitz L, Lerner E, Haudenschild C. The effect of lovastatin on intimal hyperplasia after balloon angioplasty: a study in an atherosclerotic hypercholesterolemic rabbit. J Am Coll Cardiol. 1991;17: 251-259.
30. Azrin MA. The role of antibodies in clinical cardiology. Am Heart J. 1992;124:753-768.
31. Weiss HJ, Turitto VT, Baumgartner HR. Further evidence that glycoprotein Iib-IIIa mediates platelet spreading on subendothelium. Thromb Haemost. 1991;65:202-205.
32. Golino P, Ambrosio G, Pascucci I, Ragni M, Russolillo E, Chiariello M. Experimental carotid stenosis and endothelial injury in the rabbit: an in vivo model to study intravascular platelet aggregation. Thromb Haemost. 1992;67:302-305.
33. Sigal SL, Gellman J, Sarembock IJ, Laveau PJ, Chen QS, Cabin HS, Ezekowitz MD. Effects of serotonin-receptor blockade on angioplasty-induced vasospasm in an atherosclerotic rabbit model. Anterioscler Thromb. 1991;11:770-783.
34. Laveau PJ, Sarembock IJ, Sigal SL, Yang TL, Ezekowitz MD. Vascular reactivity after balloon angioplasty in an atherosclerotic rabbit. Circulation. 1990;82:1790-1801.
35. Sarembock IJ, LaVeau PJ, Sigal SL, Timms I, Sussman J, Haudenschild C, Ezekowitz MD. Influence of inflation pressure and balloon size on the development of intimai hyperplasia after balloon angioplasty: a study in the atherosclerotic rabbit. Circulation. 1989;80:1029-1040.
36. Turitto VT, Baumgartner HR. Platelet interaction with subendothelium in flowing rabbit blood: effect of blood shear rate. Microvasc Res. 1979;17:38-54.
37. Coller BS, Scudder LE. Inhibition of dog platelet function by in vivo infusion of F(ab′)2 fragments of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor. Blood. 1985;66:1456-1459.
38. Hanson SR, Pareti FI, Ruggeri ZM, Marzec UM, Kunicki TJ, Montgomery RR, Zimmerman TS, Harker LA. Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the babboon. J Clin Invest. 1988; 81:149-158.
39. Miller J, Kupinski JM. Identification of receptors for fibrinogen and von Willebrand factor mediating aggregation in guinea pig platelets. Thromb Res. 1986;43:335-344.
40. Takami H, Nichols WL, Kaese SE, Miller RS, Katzmann JA, Bowie EJW: Monoclonal antibodies against porcine platelet membrane glycoproteins Ib and IIb/IIIa. Blood. 1988;72: 1740-1747.
41. Harfenist EJ, Wrana JL, Packham MA, Mustard JF. Measurement of fibrinogen concentrations in suspensions of washed rabbit and human platelets by radioimmunoassays. Thromb Haemost. 1985;53: 110-115.
42. Harfenist EJ, Packham MA, Mustard JF. Effects of the cell adhesion peptide, Arg-Gly-Asp-Ser, on responses of washed platelets from humans, rabbits, and rats. Blood. 1988;71:132-136.
43. Brinkhous KM, Thomas BD, Ibrahim SA, Read MS. Plasma levels of platelet aggregating factor/von Willebrand factor in various species. Thromb Res. 1977;11:345-355.
44. Hawiger J. Platelets: receptors, adhesion, secretion: part B. In: Methods in Enzymology. New York, NY: Academic Press, Inc; 1991.
45. Read MS, Potter JY, Brinkhous KM. Venom coagglutinin for detection of von Willebrand factor activity in animal plasmas. J Lab Clin Med. 1983;101:74-82.
46. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin invest. 1992;89:507-511.
47. Wilentz JR, Sanborn TA, Haudenschild CC, Valeri CR, Ryan TJ, Faxon DP. Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation. 1987;75: 636-642.
48. Steele PM, Chesebro JH, Stanson AW, Holmes DR Jr, Dewanjee MK, Badimon L, Fuster V. Balloon angioplasty: natural history of the pathophysiological response to injury in a pig model. Circ Res. 1985;57:105-112.
49. Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res. 1990;67:651-659.
50. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury, II: inhibition of smooth muscle cell growth by heparin. Lab Invest. 1985;52:611-616.
51. Berger K, Sauvage LR, Rao AM, Wood SJ. Healing of arterial prostheses in man: its incompleteness. Ann Surg. 1972;175:118-127.
52. Bauters C, de Groote P, Adamantidis Z, Delcayre C, Hamon M, Lablanche JM, Bertrand ME, Dupuis B, Swynghedauw B. Protooncogene expression in rabbit aorta after wall injury: first marker of the cellular process leading to restenosis after angioplasty? European Heart J. 1992;13:556-559.
53. Alonso DR, Starek PK, Minick CR. Studies on the pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia. Am J Pathol. 1977;87:415-422.
54. Hansson GK, Jonasson L, Seifert PS, Stemme S. Immune mechanisms in atherosclerosis: Arteriosclerosis. 1989;9:567-578.
55. Minick CR, Fabricant CG, Fabricant J, Litrenta MM. Atheroarteriosclerosis induced by infection with a Herpesvirus. Am J Pathol. 1979;96:673-706.
56. Hardin NJ, Minick CR, Murphy GE. Experimental induction of atheroarteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet, III: the role of earlier acquired fibromuscular intimai thickening in the pathogenesis of later developing atherosclerosis. Am J Pathol. 1973;73:301-327.
57. Minick CR, Murphy GE. Experimental induction of atheroarteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet, II: effect of repeatedly injected foreign protein in rabbits fed a lipid-rich cholesterol-poor diet. Am J Pathol. 1973;73:265-292.